A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer (IMPROVE)
Integrative Medicine for Patient-reported Outcomes, Values, and Experience (IMPROVE)
Sponsor: Memorial Sloan Kettering Cancer Center
This NA trial investigates Gynecologic Cancer and Gynecologic Tumor and is currently actively recruiting participants. Memorial Sloan Kettering Cancer Center leads this study, which shows 14 recorded versions since 2021 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
14 versions recorded-
Nov 2025 — Present [monthly]
Recruiting NA
-
Sep 2025 — Nov 2025 [monthly]
Recruiting NA
-
Jul 2025 — Sep 2025 [monthly]
Recruiting NA
-
Jun 2025 — Jul 2025 [monthly]
Recruiting NA
-
Jan 2025 — Jun 2025 [monthly]
Recruiting NA
▶ Show 9 earlier versions
-
Nov 2024 — Jan 2025 [monthly]
Recruiting NA
-
Sep 2024 — Nov 2024 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Nov 2023 — Jul 2024 [monthly]
Recruiting NA
-
Feb 2023 — Nov 2023 [monthly]
Recruiting NA
-
Sep 2022 — Feb 2023 [monthly]
Recruiting NA
-
May 2022 — Sep 2022 [monthly]
Recruiting NA
-
Dec 2021 — May 2022 [monthly]
Recruiting NA
-
Oct 2021 — Dec 2021 [monthly]
Recruiting NA
First recorded
Sep 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Memorial Sloan Kettering Cancer Center
For direct contact, visit the study record on ClinicalTrials.gov .